3-((4-Formylphenyl)(methyl)amino)propanenitrile, 95.0%, 5g

3-Methylbenzenesulfonamide, 97.0%, 25g

3-Nitro-1H-pyrazolo[3,4-b]pyridine, 95.0%, 250mg

2-chloro-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide, 250mg

2,3-Dichloro-4-methyl-5-(trifluoromethyl)pyridine, 95%, 100mg

2-Benzoylpyridine, 95.0%, 500g

L-γ-Azidohomoalanine hydrochloride, min. 98 %, 100 mg, kunststoffverpackung.

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate, 97%, 5g

4-Chloro-3-ethoxyaniline, 95%, 5g

GC-Kapillarsäule ROTI®Cap-1701, L 30 m, Ø-Innen 0,25 mm, Filmd. 0,50 µm, 1 Stück

2,3-Dichlorophenylboronic Acid (contains varying amounts of Anhydride)25g

1-(1,3-Benzothiazol-2-yl)-1h-pyrrole-2-carbaldehyde, 98%, 250mg

2-chloro-4,5,6-trimethylpyridin-3-amine, 95.0%, 250mg